+30.4%
GSK vs INDA
-5.0%
+35.4%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | INDA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | 0.0% | -1.9% | -1.9% |
| 7D | -1.8% | +0.7% | -2.5% | -2.1% |
| 30D | -2.2% | -0.8% | -1.4% | -1.9% |
| 3M | -1.8% | +3.9% | -5.7% | -3.3% |
| 6M | -10.6% | -0.7% | -9.9% | -10.8% |
| YTD | +4.4% | -7.7% | +12.1% | +5.1% |
| 1Y | +30.4% | -5.1% | +35.5% | +31.5% |
| All | +30.4% | -5.0% | +35.4% | +31.5% |
Cumulative growth
Daily Returns
Daily percentage return beside INDA.
Daily Out/Under-Performance
Portfolio return minus INDA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INDA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded INDA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling